COVID-19 and return to campus information.
UCR biomedical scientist joins international SARS-CoV-2 group assembled by NIAID
SAVE focuses on mutations in SARS-CoV-2 and emerging virus variants
Experts urge reconsideration of 'standard' for time-keeping
To gauge the impacts of dark mornings in some parts of the country, we spoke with two UC Riverside experts
Should you get a second booster shot for COVID-19?
UC Riverside’s Dr. David Lo, a vaccine expert, shares his thoughts
A potential antiviral for SARS and SARS-like coronaviruses
UC Riverside-led study shows how an effective therapy against SARS-CoV-2 could be developed
Commencement 2022 to be in person and on campus
UC Riverside’s class of 2022 will celebrate the milestone of receiving their bachelor's, master's, and doctoral degrees in person and on campus. In early June, the campus will finally welcome graduating Highlanders to the commencement stage, where their friends, families, and fans can cheer them on as they cross the...
Scientists profile FDA-approved drugs to potentially treat hundreds of genetic disorders
New method developed by UC Riverside researchers quickly assesses drug potential for rare disorders
Researchers develop molecular traps to target SARS-CoV-2
Joint effort by UC Riverside and UCLA scientists aims to stop the COVID-19-spreading virus from attacking immune cells
Scientists discover new avian immunological pathway
UC Riverside-led team identifies a new host protein interaction that produces a robust immune response to viral infection in birds and may lead to better poultry vaccines
Building robust collaborations to ‘ATTACK’ future pandemics
As the COVID-19 pandemic continues, the development of antiviral drug treatments has become a critical weapon in our arsenal against the virus. Harnessing the research and scientific brainpower needed to treat and prevent the next pandemic is the University of California - National Labs Antiviral Treatments Targeting All Coronaviruses and...
Is it time to wear a highly efficient medical grade facemask?
UC Riverside experts weigh in
A more targeted therapy to treat inflammatory bowel disease
UC Riverside mouse study focuses on the receptor TNFR1
New hope for people living with a genetic cause of autism
UC Riverside research shows gene reactivation can be used to treat Fragile X syndrome
O my, here’s Omicron
UC Riverside experts share their thoughts on the new COVID-19 variant
Deafness trumps HIV for deaf people living with HIV
UC Riverside-led study participants advocate for collection of more data on deaf individuals
New model links cultural trauma with health inequalities
UC Riverside researchers offer new interpretation of cultural trauma
New School of Medicine building begins construction
UC Riverside began construction Friday, Oct. 22 of a new School of Medicine building that will allow for growing class sizes and increasing the number of physicians trained in the underserved Inland Southern California. Campus and community leaders celebrated the start of the project at a groundbreaking ceremony at the...
How sepsis need not be fatal
UC Riverside-led team identifies molecular driver and protector of this life-threatening medical emergency
Why is it taking so long to approve a COVID-19 vaccine for kids?
UC Riverside vaccine expert David Lo explains
Public lecture to focus on synthetic genome engineering
Lei Stanley Qi of Stanford University will give the 2021 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside
Medical school led the way for safe return to classrooms
The School of Medicine has lessons to share after several months of in-person classes with no documented cases of COVID-19 transmission